Case Studies in Cross-Border Care: From Global Inbound to Outbound Excellence

Max Kirkby spent 35 years in the Pharma industry. An experienced drug development leader, leading both global cross-function drug development teams, development functions and R&D organisations.

During his development career Max brought to market a number of new medicines across multiple therapy areas. Within oncology he has led teams through approvals with US FDA, EMA, PMDA and NMPA including assets with companion diagnostic registration requirements.

Max has lived and worked in UK, USA, Sweden and China and managed development teams globally and R&D organisations in China and Japan. He is an engaging leader who puts a strong emphasis on high-performing teams, individual development, cross-functional working and good governance to drive successful drug development.

Max has more than 14 years experience living and working in China in both global and local leadership roles and is passionate about the importance of including China and other Asian countries like Japan and S Korea in global development from an early stage. This enables both the diversity of expertise from these important countries to be hanced within the global development strategy as well as ensure their patients can access new treatment options at the same time as those in the US and Europe.

Dr. Hsiang joined Jiahui full-time in 2016, served as the Chief Medical Officer. In 2020-2024, He was the President of the Shanghai Jiahui International Hospital. Starting 2024, he became the Chairman of the Jiahui Health Executive Committee. Dr. Hsiang received his MD and Ph.D. degrees from the University of Chicago. He completed his internship and neurosurgical residency training at the University of California San Diego. Prior to joining Jiahui Health, he served as the Director of Neurosurgery at Swedish Neuroscience Institute in Seattle. With more than 30 years of clinical experience in Neurosurgery, Dr. Hsiang also specialized in minimally invasive spine surgery, and cervical arthroplasty. Dr. Hsiang is board certified in American Board of Neurological Surgery, and American Board of Spine Surgery. He is also a member of American College of Physician Executives, American Association of Neurological Surgeons, North American Spine Society and American College of Spine Surgeons. Dr. Hsiang engages in the worldwide Chinese Neurosurgery Conferences and Spine Conferences to enhance the influential and status of Chinese physicians in neurosurgery and spine surgery. Dr. Hsiang is also the Vice Chairman of International Chinese Spine Society and a council member of the Orthopedics Committee of the Chinese Association in Non-Public Medical Institutions. He is committed to encourage development and cooperation of Neurosurgery and Spine surgery in China.